1. Home
  2. STN vs NBIX Comparison

STN vs NBIX Comparison

Compare STN & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STN
  • NBIX
  • Stock Information
  • Founded
  • STN 1954
  • NBIX 1992
  • Country
  • STN Canada
  • NBIX United States
  • Employees
  • STN N/A
  • NBIX N/A
  • Industry
  • STN Military/Government/Technical
  • NBIX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • STN Consumer Discretionary
  • NBIX Health Care
  • Exchange
  • STN Nasdaq
  • NBIX Nasdaq
  • Market Cap
  • STN 9.8B
  • NBIX 11.0B
  • IPO Year
  • STN N/A
  • NBIX 1996
  • Fundamental
  • Price
  • STN $87.32
  • NBIX $101.38
  • Analyst Decision
  • STN
  • NBIX Strong Buy
  • Analyst Count
  • STN 0
  • NBIX 21
  • Target Price
  • STN N/A
  • NBIX $163.00
  • AVG Volume (30 Days)
  • STN 196.1K
  • NBIX 1.8M
  • Earning Date
  • STN 05-14-2025
  • NBIX 05-05-2025
  • Dividend Yield
  • STN 0.70%
  • NBIX N/A
  • EPS Growth
  • STN 11.38
  • NBIX 33.20
  • EPS
  • STN 2.20
  • NBIX 3.29
  • Revenue
  • STN $4,077,312,279.00
  • NBIX $2,355,300,000.00
  • Revenue This Year
  • STN $10.69
  • NBIX $15.48
  • Revenue Next Year
  • STN $7.02
  • NBIX $15.99
  • P/E Ratio
  • STN $39.59
  • NBIX $30.81
  • Revenue Growth
  • STN 15.80
  • NBIX 24.81
  • 52 Week Low
  • STN $73.18
  • NBIX $84.23
  • 52 Week High
  • STN $90.24
  • NBIX $157.98
  • Technical
  • Relative Strength Index (RSI)
  • STN 60.19
  • NBIX 46.65
  • Support Level
  • STN $77.07
  • NBIX $84.23
  • Resistance Level
  • STN $86.08
  • NBIX $112.74
  • Average True Range (ATR)
  • STN 2.62
  • NBIX 5.17
  • MACD
  • STN 0.43
  • NBIX 0.59
  • Stochastic Oscillator
  • STN 95.44
  • NBIX 60.45

About STN Stantec Inc

Stantec Inc is a sustainable engineering, architecture, and environmental consulting company. It offers services through the following business operating units; Environmental Services, Infrastructure, Water, Buildings, and Energy & Resources. Maximum revenue is derived from its Infrastructure business unit, which is engaged in evaluating, planning, and designing infrastructure solutions for transportation, community development, and urban spaces. The company's reportable segments are the United States, which derives maximum revenue, Canada, and Global. These segments provide consulting in engineering, architecture, interior design, landscape architecture, surveying, environmental sciences, project management, and project economics services in the area of infrastructure and facilities.

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.

Share on Social Networks: